市場調查報告書
商品編碼
1368721
蛋白質純化與分離市場技術[製備層析、(親和、離子交換)、超濾]、產品[消耗品(試劑盒、試劑)、儀器]、應用、最終用戶、2023 - 2032 年全球預測Protein Purification & Isolation Market-Technology [Preparative Chromatography, (Affinity, Ion Exchange), Ultrafiltration], Product [Consumable (Kit, Reagent), Instrument], Application, End-user, Global Forecast 2023 - 2032 |
在色譜、電泳和過濾技術不斷進步的推動下,蛋白質純化和分離市場規模預計從 2023 年到 2032 年將以 10.5% 的年複合成長率擴大。這些技術在解析度、速度和可擴展性方面的改進能力顯著增強了純化過程,使研究人員和生物製藥公司能夠分離出用於各種治療和診斷應用的高品質蛋白質。
包括胰島素和抗體在內的蛋白質藥物的生產速度不斷上升,導致對蛋白質純化的需求更高。持續進行的有助於降低生產成本的研發工作也將支持市場成長。例如,2023 年 2 月,麻省理工學院的工程師設計了一種新的純化方法,透過部署專門的奈米粒子來快速結晶蛋白質,使發展中國家更容易獲得和負擔得起蛋白質藥物。
蛋白質純化和分離產業分為技術、產品、應用、最終用戶和地區。
就技術而言,到2032 年,超濾領域的市場價值可能會顯著成長。這一成長可歸因於擴大採用該技術,以選擇性保留蛋白質,同時消除污染物,從而簡化純化工作流程並確保高產量純蛋白質。此外,對成本效益、可擴展性和溫和操作條件的需求不斷增加,使得超濾技術在各種生物製藥和研究應用中越來越受到青睞。
在應用方面,藥物篩選領域的蛋白質純化和分離行業在2022 年產生了可觀的收入,預計到2032 年將實現強勁成長。對藥物發現和開發的日益關注,加上對高質量純化蛋白質的需求不斷成長臨床前和臨床研究正在推動先進純化和分離技術的採用。純化蛋白在理解疾病機制和開發個人化療法的應用將進一步加速細分市場的擴張。
從地區來看,由於生物製藥和生物技術產業的強勁發展,歐洲蛋白質純化和分離市場預計將在 2023 年至 2032 年期間呈現強勁成長。對研發活動的大量投資以及對個人化醫療和標靶治療的日益重視正在推動對先進蛋白質純化和分離技術的需求。此外,完善的醫療基礎設施以及對學術研究和產業合作的高度重視將增強該地區的產業前景。
Protein Purification and Isolation Market size is estimated to expand at 10.5% CAGR from 2023-2032 driven by the continual advancements in chromatography, electrophoresis, and filtration technologies. The improved capabilities of these technologies in terms of resolution, speed, and scalability is significantly enhancing the purification process for enabling researchers and biopharmaceutical companies to isolate high-quality proteins for various therapeutic and diagnostic applications.
The rising rate of manufacturing of protein drugs, including insulin and antibodies is leading to the higher need for purification of protein. The ongoing R&D efforts to help reduce the production costs will also support the market growth. For instance, in February 2023, MIT engineers devised a new way to perform purification by deploying specialized nanoparticles to rapidly crystallize proteins for making protein drugs more accessible and affordable in developing countries.
The protein purification & isolation industry is segmented into technology, product, application, end-user, and region.
With respect to technology, the market value from the ultrafiltration segment is likely to gain significant traction through 2032. The growth can be attributed to the growing adoption of this technology to selectively retain proteins while eliminating contaminants for streamlining the purification workflow and ensuring high yields of pure proteins. Additionally, the surging need for cost-effectiveness, scalability, and gentle operating conditions are contributing to the increasing preference for ultrafiltration technology in various biopharmaceutical and research applications.
In terms of application, the protein purification & isolation industry from the drug screening segment generated substantial revenue in 2022 and is projected to record robust growth through 2032. The increasing focus on drug discovery and development coupled with the rising demand for high-quality purified proteins for preclinical and clinical research is propelling the adoption of advanced purification and isolation techniques. The application of purified proteins in understanding disease mechanisms and developing personalized therapeutics will further accelerate the segment expansion.
Regionally, Europe protein purification & isolation market is set to exhibit robust growth from 2023 to 2032 attributed to the presence of robust biopharmaceutical and biotechnology sectors. Massive investments in R&D activities along with the growing emphasis on personalized medicine and targeted therapeutics are fueling the demand for advanced protein purification and isolation technologies. Moreover, the presence of well-established healthcare infrastructure and the strong focus on academic research and industrial collaborations will augment the regional industry outlook.